FeNO, a potential biomarker for evaluating glucocorticoids treatment and prognosis in ABPA.
Zhang LS, Wu YF, Lu HW, Wang L, Xu JY, Gu SY, Mao B, Yu L, Li JX, Weng D, Xu JF.
Zhang LS, et al. Among authors: weng d.
Ann Allergy Asthma Immunol. 2024 May 20:S1081-1206(24)00305-3. doi: 10.1016/j.anai.2024.05.010. Online ahead of print.
Ann Allergy Asthma Immunol. 2024.
PMID: 38777120